Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Soligenix (SNGX)
NASDAQ:SNGX
Holding SNGX?
Track your performance easily
SNGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.83 - $14.91
Previous CloseN/A
Volume55.16K
Average Volume (3M)430.53K
Market Cap
$6.42M
Enterprise Value$1.11M
Total Cash (Recent Filing)$8.77M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.49
Next Earnings
Apr 01, 2025EPS Estimate
-0.95Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.80
Shares Outstanding2,509,499
10 Day Avg. Volume1,204,948
30 Day Avg. Volume430,526
Standard Deviation0.30
R-Squared0.09
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)17.64
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market Cap0.17
Enterprise Value/Revenue3.05
Enterprise Value/Gross Profit11.43
Enterprise Value/Ebitda-0.15
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Soligenix News
Ownership Overview
18.48%
Insiders
0.38% Mutual Funds
1.86% Other Institutional Investors
79.16% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SNGX FAQ
What was Soligenix’s price range in the past 12 months?
Soligenix lowest stock price was $1.83 and its highest was $14.91 in the past 12 months.
What is Soligenix’s market cap?
Soligenix’s market cap is $6.42M.
When is Soligenix’s upcoming earnings report date?
Soligenix’s upcoming earnings report date is Apr 01, 2025 which is in 59 days.
How were Soligenix’s earnings last quarter?
Soligenix released its earnings results on Nov 08, 2024. The company reported -$0.78 earnings per share for the quarter, beating the consensus estimate of -$1.39 by $0.61.
Is Soligenix overvalued?
According to Wall Street analysts Soligenix’s price is currently Overvalued.
Does Soligenix pay dividends?
Soligenix does not currently pay dividends.
What is Soligenix’s EPS estimate?
Soligenix’s EPS estimate is -0.95.
How many shares outstanding does Soligenix have?
Soligenix has 2,509,499 shares outstanding.
What happened to Soligenix’s price movement after its last earnings report?
Soligenix reported an EPS of -$0.78 in its last earnings report, beating expectations of -$1.39. Following the earnings report the stock price went up 0.865%.
Which hedge fund is a major shareholder of Soligenix?
Currently, no hedge funds are holding shares in SNGX
---
Company Description
Soligenix
Soligenix, Inc. engages in the development and commercialization of products to treat rare disease. It operates through the following segments: BioTherapeutics and Vaccines/BioDefense. The BioTherapeutics segment offers photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Vaccines/BioDefense segment includes active development programs for RiVax, ricin toxin vaccine candidate, OrbeShield, GI acute radiation syndrome therapeutic candidate, and SGX943, melioidosis therapeutic candidate. The company was founded in 1987 and is headquartered Princeton, NJ.
---
Technical Analysis
---